BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18342190)

  • 1. Longitudinal association between prostatitis and development of benign prostatic hyperplasia.
    St Sauver JL; Jacobson DJ; McGree ME; Girman CJ; Lieber MM; Jacobsen SJ
    Urology; 2008 Mar; 71(3):475-9; discussion 479. PubMed ID: 18342190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC; Elhilali M; Vallancien G;
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
    Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
    S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
    van Vuuren SP; Heyns CF; Zarrabi AD
    BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk.
    Hung SC; Lai SW; Tsai PY; Chen PC; Wu HC; Lin WH; Sung FC
    Br J Cancer; 2013 May; 108(9):1778-83. PubMed ID: 23612451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of prostate tissue inflammation in benign prostatic hyperplasia on enhancer of zeste homolog 2 ribonucleic acid expression.
    Al-Maghrebi M; Kehinde EO; Al-Mulla F; Anim JT
    Ann Saudi Med; 2012; 32(3):262-8. PubMed ID: 22588437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis.
    Nickel JC
    Curr Opin Urol; 2006 Jan; 16(1):5-10. PubMed ID: 16385194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort.
    Collins MM; Meigs JB; Barry MJ; Walker Corkery E; Giovannucci E; Kawachi I
    J Urol; 2002 Mar; 167(3):1363-6. PubMed ID: 11832733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Basal Cell Hyperplasia Is not Associated With Baseline Lower Urinary Tract Symptoms, Baseline Clinical Prostatitis or Prostate Cancer in Repeat Biopsies.
    Freitas D; Andriole GL; Freedland SJ; Neto BS; Moreira DM
    Urology; 2019 Jul; 129():160-164. PubMed ID: 30914334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of benign prostate hyperplasia with prostatitis].
    Long Z; He L; Zhong K; Zhang Y; Yue D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 35(4):381-5. PubMed ID: 20448364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of chronic periodontitis with prostatic hyperplasia and prostatitis: A population-based cohort study in Taiwan.
    Fu E; Cheng CM; Chung CH; Lee WC; Chen WL; Sun GH; Chien WC
    J Periodontol; 2021 Jan; 92(1):72-86. PubMed ID: 32627845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
    Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
    Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of histological prostatitis on sexual function and lower urinary tract symptoms in patients with benign prostatic hyperplasia.
    Wang GC; Zheng JH; Yang B; Che JP; Yan Y; Geng J; Liu M; Huang JH; Xia SQ; Peng B
    Urology; 2013 Nov; 82(5):1094-7. PubMed ID: 23915513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
    Wu XJ; Yang LY; Zhang XZ
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of using outcomes in the placebo arm of a clinical trial of benign prostatic hyperplasia to quantify those in the community.
    Roberts RO; Lieber MM; Jacobson DJ; Girman CJ; Jacobsen SJ
    Mayo Clin Proc; 2005 Jun; 80(6):759-64. PubMed ID: 15948299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of IPSS with IL-8 and COX-2 levels in patients with benign prostatic hyperplasia and prostatitis].
    Chen DA; Yang XZ; Zhang PH; Li GS; Chang DG
    Zhonghua Nan Ke Xue; 2013 Jun; 19(6):527-30. PubMed ID: 23862231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
    Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
    J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benign prostate hyperplasia with chronic prostatitis: an update].
    Ma Y; Zhang WL
    Zhonghua Nan Ke Xue; 2010 Jul; 16(7):646-50. PubMed ID: 20873602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia?
    Mishra VC; Allen DJ; Nicolaou C; Sharif H; Hudd C; Karim OM; Motiwala HG; Laniado ME
    BJU Int; 2007 Aug; 100(2):327-31. PubMed ID: 17617139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Calcium Oxalate on Expression of Clusterin and Lower Urinary Tract Symptoms in Prostatitis and Benign Prostatic Hyperplasia Patients with Calculi.
    Sun C; Xie G; Huang F; Liu X
    Med Sci Monit; 2018 Dec; 24():9196-9203. PubMed ID: 30560838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.